Startup database

Pharma & Drug Discovery

Target discovery, molecule design and translational tooling, increasingly compute first.

17 companies

Recursion Pharmaceuticals

AI drug discovery

Combines automation and machine learning to industrialize drug discovery and development.

Public$665M raisedSalt Lake City, United States

Relay Therapeutics

Structure based design

Applies structural biology and computational chemistry to target protein motion.

Public$520M raisedCambridge, United States

Exscientia

AI drug discovery

Signal 100

Uses AI to design patient first precision medicines and optimize clinical trials.

Public$440M raisedOxford, United Kingdom

Valo Health

AI drug discovery

Signal 100

Integrates human data and machine learning to accelerate therapeutic discovery.

Series C+$439M raisedBoston, United States

Schrodinger

Computational chemistry

Signal 100

Provides physics based software solutions to accelerate molecular discovery and design.

Public$410M raisedNew York, United States

Insilico Medicine

AI drug discovery

Signal 100

Applies generative AI to discover new drug candidates and identify novel disease targets.

Series C+$401M raisedHong Kong, China

BenevolentAI

AI drug discovery

Employs an artificial intelligence platform to discover novel therapies for complex diseases.

Public$300M raisedLondon, United Kingdom

Genesis Therapeutics

AI drug discovery

Signal 100

Uses deep learning and molecular simulations to discover small molecule drugs.

Series B$280M raisedBurlingame, United States

AbCellera

Antibody discovery

Discovers and develops antibody therapeutics using high throughput microfluidics.

Public$245M raisedVancouver, Canada

Terray Therapeutics

AI drug discovery

Signal 100

Combines ultra high throughput chemical synthesis with AI to find small molecules.

Series B$200M raisedPasadena, United States

Atomwise

AI drug discovery

Utilizes deep learning for structure based small molecule drug discovery.

Series B$174M raisedSan Francisco, United States

Unlearn.AI

Clinical trial design

Creates digital twins of patients to run smaller and faster clinical trials.

Series C+$130M raisedSan Francisco, United States

Causaly

Literature search and synthesis

Accelerates scientific research discovery through artificial intelligence driven literature synthesis.

Series B$93M raisedLondon, United Kingdom

Peptone

Protein therapeutics

Designs therapeutic proteins using biophysics and advanced computational modeling.

Series A$40M raisedLondon, United Kingdom

VeriSIM Life

Translational prediction

Predicts clinical success of drug candidates using biosimulation and machine learning.

Series A$25M raisedSan Francisco, United States

Iktos

AI drug discovery

Develops generative AI models for automated de novo drug design.

Series A$16M raisedParis, France

InSilicoTrials

Clinical trial simulation

Provides computational modeling and simulation software for virtual drug trials.

Series A$10M raisedTrieste, Italy